Document Detail

Automated volumetric growth plate measurement using magnetic resonance imaging for monitoring skeletal toxicity in children treated on investigational drug trials.
MedLine Citation:
PMID:  21807634     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Targeted anticancer agents have been reported to have side effects on the skeletal system such as thickening of the epiphyseal growth plate in preclinical models of juvenile, but not mature, animals. Careful evaluation of skeletal toxicity in the clinical development of targeted therapies for children is required. We validated a novel method to measure the growth plate volume using MRI.
EXPERIMENTAL DESIGN: A semiautomated method of volumetric growth plate measurement was developed on the basis of the differences of pixel intensity of the growth plate from surrounding bone on T(1) sagittal MRI. Two observers measured the femoral growth plate volume and thickness on three different days using 20 pediatric knee MRIs obtained at the NIH. Five subjects had two knee MRIs obtained on the same day to evaluate intrasubject reproducibility.
RESULTS: Volumetric analysis showed low intraobserver variability, with the coefficient of variation for the two observers ranging from 0.2% to 6.1%. Interobserver correlation was 0.99, and good concordance was shown with a mean volume difference of -1.8 mm(3). One-dimensional measurements had poorer intra and interobserver consistency. No statistically significant differences in volumetric measurements were observed between the two scans done on the same day in five subjects (P = 0.5).
CONCLUSIONS: MRI volumetric growth plate measurement is a reproducible and sensitive method to evaluate meaningful growth plate volume changes over time. This tool, along with close monitoring of height and laboratory evaluations for bone metabolism, may be used to evaluate potential bone and growth toxicities of children enrolled in trials of investigational drugs.
AeRang Kim; Eva Dombi; Jeffrey Solomon; Elizabeth Fox; Frank M Balis; Brigitte C Widemann
Related Documents :
25440994 - Mri for local staging of endometrial carcinoma: is endovenous contrast medium administr...
22057214 - Standardisation of liver mdct by tracking liver parenchyma enhancement to trigger imaging.
17415174 - Combined x-ray and magnetic resonance imaging facility: application to image-guided ste...
21940964 - Postcontrast susceptibility-weighted imaging: a novel technique for the detection of ar...
14516554 - Detection of recurrent brain tumor. comparison of mr registered camera-based and dedica...
10373024 - Fast tissue segmentation based on a 4d feature map in characterization of intracranial ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Validation Studies     Date:  2011-08-01
Journal Detail:
Title:  Clinical cancer research : an official journal of the American Association for Cancer Research     Volume:  17     ISSN:  1078-0432     ISO Abbreviation:  Clin. Cancer Res.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-19     Completed Date:  2012-01-17     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  9502500     Medline TA:  Clin Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5982-90     Citation Subset:  IM    
Copyright Information:
©2011 AACR.
Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / toxicity*
Child, Preschool
Drug Monitoring*
Drugs, Investigational / toxicity*
Growth Plate / drug effects*
Magnetic Resonance Imaging*
Observer Variation
Reproducibility of Results
Sensitivity and Specificity
Grant Support
Reg. No./Substance:
0/Antineoplastic Agents; 0/Drugs, Investigational

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the perip...
Next Document:  Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction...